Evidence map›Paper›PMID 26888427›Full record

ArticleJournal of the American Heart Association2016

Ndufc2 Gene Inhibition Is Associated With Mitochondrial Dysfunction and Increased Stroke Susceptibility in an Animal Model of Complex Human Disease.

Speranza Rubattu, Sara Di Castro, Herbert Schulz, Aron M Geurts, Maria Cotugno, Franca Bianchi, Henrike Maatz, Oliver Hummel, Samreen Falak, Rosita Stanzione and 12 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 78 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Impact of aFrontiers in cardiovascular medicine · 2022
    Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 8 institutions in 3 countries.

Speranza RubattuIRCCS Neuromed, Pozzilli (Isernia), Italy Department of Clinical and Molecular Medicine, School of Medicine and Psychology, Sapienza University of Rome, Ospedale S. Andrea, Rome, Italy rubattu.speranza@neuromed.it.
Sara Di CastroIRCCS Neuromed, Pozzilli (Isernia), Italy.
Herbert SchulzZentrum fur Molecular Medicine-MDC, Berlin, Germany.
Aron M GeurtsDepartment of Physiology and Human and Molecular Genetics Center, Medical College of Wisconsin, Milwaukee, WI.
Maria CotugnoIRCCS Neuromed, Pozzilli (Isernia), Italy.
Franca BianchiIRCCS Neuromed, Pozzilli (Isernia), Italy.
Henrike MaatzZentrum fur Molecular Medicine-MDC, Berlin, Germany.
Oliver HummelZentrum fur Molecular Medicine-MDC, Berlin, Germany.
Samreen FalakZentrum fur Molecular Medicine-MDC, Berlin, Germany.
Rosita StanzioneIRCCS Neuromed, Pozzilli (Isernia), Italy.
Simona MarchittiIRCCS Neuromed, Pozzilli (Isernia), Italy.
Stefania ScarpinoDepartment of Cytology and Histology, School of Medicine and Psychology, University Sapienza of Rome, Ospedale S. Andrea, Rome, Itlay.
Betti GiustiDepartment of Experimental and Clinical Medicine, University of Florence, Italy Atherothrombotic Disease Center, AOU Careggi, Florence, Italy.
Ada KuraDepartment of Experimental and Clinical Medicine, University of Florence, Italy Atherothrombotic Disease Center, AOU Careggi, Florence, Italy.
Gian Franco GensiniDepartment of Experimental and Clinical Medicine, University of Florence, Italy Department of Cardiothoracovascular Medicine, AOU Careggi, Florence, Italy Don Carlo Gnocchi Foundation, Florence, Italy.
Flora PeyvandiIRCCS Ca' Granda Maggiore Policlinico Hospital Foundation, Milan, Italy.
Pier Mannuccio MannucciIRCCS Ca' Granda Maggiore Policlinico Hospital Foundation, Milan, Italy.
Maurizia RasuraStroke Unit, School of Medicine and Psychology, Sapienza University of Rome, Ospedale S. Andrea, Rome, Italy.
Sebastiano SciarrettaIRCCS Neuromed, Pozzilli (Isernia), Italy Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy.
Melinda R DwinellDepartment of Physiology and Human and Molecular Genetics Center, Medical College of Wisconsin, Milwaukee, WI.
Norbert HubnerZentrum fur Molecular Medicine-MDC, Berlin, Germany.
Massimo VolpeIRCCS Neuromed, Pozzilli (Isernia), Italy Department of Clinical and Molecular Medicine, School of Medicine and Psychology, Sapienza University of Rome, Ospedale S. Andrea, Rome, Italy.
Istituto Neurologico Mediterraneo · ITMax Delbrück Center · DEAzienda Ospedaliera Sant'Andrea · ITAzienda Ospedaliero-Universitaria Careggi · ITMedical College of Wisconsin · USFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITUniversity of Florence · IT

Funding

Mechanistic characterization of genes for hypertension and renal disease.RC2HL101681 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI JACOB, HOWARD J · 2009 to 2010
$6.6M
Advanced genetic engineering technology developmentDP2OD008396 · OD · MEDICAL COLLEGE OF WISCONSIN · PI GEURTS, ARON M · 2011 to 2011
$2.3M
NHLBI NIH HHS RC2 HL101681NIH HHS DP2 OD008396NIH HHS DP2-OD008396
6 · The paper itself

Abstract

backgroundThe genetic basis of stroke susceptibility remains to be elucidated. STR1 quantitative trait locus (STR1/QTL) was identified on rat chromosome 1 of stroke-prone spontaneously hypertensive rat (SHRSP) upon Japanese-style stroke-permissive diet (JD), and it contributes to 20% of the stroke phenotype variance. METHODS AND

resultsNine hundred eighty-six probe sets mapping on STR1 were selected from the Rat RAE230A array and screened through a microarray differential expression analysis in brains of SHRSP and stroke-resistant SHR (SHRSR) fed with either regular diet or JD. The gene encoding Ndufc2 (NADH dehydrogenase [ubiquinone] 1 subunit), mapping 8 Mb apart from STR1/QTL Lod score peak, was found significantly down-regulated under JD in SHRSP compared to SHRSR. Ndufc2 disruption altered complex I assembly and activity, reduced mitochondrial membrane potential and ATP levels, and increased reactive oxygen species production and inflammation both in vitro and in vivo. SHRSR carrying heterozygous Ndufc2 deletion showed renal abnormalities and stroke occurrence under JD, similarly to SHRSP. In humans, T allele variant at NDUFC2/rs11237379 was associated with significant reduction in gene expression and with increased occurrence of early-onset ischemic stroke by recessive mode of transmission (odds ratio [OR], 1.39; CI, 1.07-1.80; P=0.012). Subjects carrying TT/rs11237379 and A allele variant at NDUFC2/rs641836 had further increased risk of stroke (OR=1.56; CI, 1.14-2.13; P=0.006).

conclusionsA significant reduction of Ndufc2 expression causes complex I dysfunction and contributes to stroke susceptibility in SHRSP. Moreover, our current evidence may suggest that Ndufc2 can contribute to an increased occurrence of early-onset ischemic stroke in humans.

Indexed as

Adenosine TriphosphateAdultAge of OnsetAnimalsBrainCell LineChi-Square DistributionDatabases, GeneticDisease Models, AnimalElectron Transport Complex IGene DeletionGene Expression ProfilingGene FrequencyGenetic Predisposition to DiseaseHeterozygoteHumansAdenosine TriphosphateElectron Transport Complex INDUFC2 protein, humanNdufc2 protein, ratcomplex Iearly‐onset ischemic strokeknockout rat modelmitochondriaNdufc2stroke‐prone spontaneously hypertensive rat

Identifiers

PMID26888427
PMCPMC4802485
OpenAlexW2308516605

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.